Therapeutics News

MIAMI BEACH, Fla. — Speakers at South Beach Symposium walked practitioners through the hair loss treatment journey from start to finish.

MIAMI BEACH, Fla. — The changing of seasons and geographical location may affect the utilization of photodynamic therapy for the treatment of actinic keratoses, according to a speaker at South Beach Symposium.

MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.

The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study.

Patients with hidradenitis suppurativa are hesitant to use adalimumab — which is recommended as a first-line treatment for the skin condition — as well as other biologics, according to a study.

Ycanth has received a permanent J-code from the Centers for Medicare & Medicaid Services, Verrica Pharmaceuticals announced in a press release.

In addition to cutting edge content, the 22nd annual South Beach Symposium has added a “unique session” that focuses on how the medical and cosmetic dermatologist can work together to holistically treat patients.

A potassium titanyl-phosphate laser has shown to have similar efficacy and less pain when compared with pulsed dye lasers in treating port wine birthmarks, according to a study.

Following the bankruptcy of Timber Pharmaceuticals, LEO Pharma has finalized the acquisition of TMB-001 and other assets from Timber, according to a press release.

Video education about topical corticosteroids alleviated caregivers’ concerns and improved outcomes for pediatric patients with eczematous dermatitis, according to a study published in Pediatric Dermatology.